Skip to main content

2016 NCI SBIR Workshop on Facilitating the Development of Molecularly Targeted Radiotherapy

November 10, 2016

National Cancer Institute Shady Grove Campus Rockville/MD

Add to Outlook Calendar

Event Overview

As part of its continued effort to support awardee companies' journey to commercialization, NCI SBIR Development Center hosted a specialized workshop for awardee companies developing molecularly targeted radiotherapy. The Workshop on Facilitating the Development of Molecularly Targeted Radiotherapy (hereinafter TRT Workshop) brought together experts from the SBIR program, NCI Radiation Research program, Food and Drug Administration's Center for Drug Evaluation and Research (FDA CDER), and Department of Energy's Isotope program to introduce the regulatory and clinical processes relevant to workshop participants.

 

2016 Workshop Agenda:
Time
Session

9:00AM - 9:15AM

Welcome from Michael Weingarten, Director NCI SBIR

9:15AM - 9:25AM

Introduction to the Workshop’s Objectives, Deepa Narayanan (NCI SBIR)

9:25AM - 10:45    

Awardee Introductions (2-3 minutes per awardee organization). Each awardee organization will provide a quick introduction of their company/institution, basic technology, and their current project.

10:45AM - 11:00AM

Break

11:00AM - 11:45AM 

Pre-clinical considerations for TRT technologies Dr. Haleh Saber, Deputy Director, Division of Hematology Oncology Toxicology/ OHOP/CDER

11:45AM - 12:30PM  

Clinical considerations for TRT technologies Dr. Amanda Walker, Medical Officer, Division of Oncology Products 1, CDER/FDA

12:30PM - 1:30PM

Lunch/ Networking

1:30PM - 2:15PM

Information about DoE’s Isotope Program and Access to Isotopes Dr. Marc Garland, Deputy Director, Department of Energy Isotope Program

2:15PM - 2:30PM

Break

2:30PM - 4:30PM

Interactive discussion with the DOE & FDA, Moderated by Dr.Jacek Capala (NCI RRP)

4:30PM - 4:45PM Closing Remarks